TELA Earnings & Financial Statements
TELA Bio, Inc.
$1.10
+$0.03(+2.82%)
54
Overall
50
Value
58
Tech
55
Quality
Market Cap
$49.43M
Volume
107.89K
52W Range
$0.50 - $1.56
Target Price
$2.08
TELA earnings and financial statements: TELA Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TELA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $80.28M | $69.30M | $58.45M | $41.42M | $29.46M |
| Cost of revenue | $25.95M | $22.43M | $17.96M | $14.37M | $10.65M |
| Operating income | -$33.76M | -$34.12M | -$44.08M | -$39.01M | -$29.45M |
| EBITDA | -$32.36M | -$39.27M | -$40.64M | -$39.05M | -$29.14M |
| Net income | -$38.83M | -$37.84M | -$46.66M | -$44.30M | -$33.28M |
| EPS (diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $81.42M | $86.57M | $78.05M | $67.86M | $62.54M |
| Total liabilities | $75.11M | $58.11M | $59.17M | $53.55M | $42.45M |
| Shareholders’ equity | $6.31M | $28.46M | $18.88M | $14.30M | $20.10M |
| Cash and equivalents | $50.84M | $52.67M | $46.73M | $42.02M | $43.93M |
| Long-term debt | $55.65M | $41.12M | $40.52M | $39.92M | $31.49M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$28.22M | -$41.59M | -$40.86M | -$40.75M | -$30.43M |
| Capital expenditure | $846.0K | $4.45M | -$611.0K | -$1.87M | -$627.0K |
| Free cash flow | -$28.67M | -$42.58M | -$41.47M | -$42.62M | -$31.06M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TELA | $1.10 | +2.8% | 107.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |